Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights Genetics Investing
NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market Medical Device Investing
Hemispherx Reports 2018 Third Quarter and First Nine Months Financial Results Pharmaceutical Investing
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 Pharmaceutical Investing
Relay Medical Introduces the Pharmatrac Technology and Reports on Development Medical Device Investing
